Placebo-Controlled, Single and Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986089 in Healthy Adult Subjects
Clinical trial NCT02145234 · COMPLETED
Trial details
- NCT number
- NCT02145234
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-30
- Primary completion
- 2016-02-29
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.